Cliff Asness's ADCT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 237,637 shares of ADC Therapeutics SA (ADCT) worth $891,141, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Cliff Asness has maintained this position in ADCT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 161,808 shares. Largest reduction occurred in Q2 2025, reducing 60,590 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ADC Therapeutics (ADCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADC Therapeutics (ADCT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +31,061 | Add 15.04% | 237,637 | $3.75 |
| Q4 2025 | +61,324 | Add 42.22% | 206,576 | $3.53 |
| Q3 2025 | +4,672 | Add 3.32% | 145,252 | $4.00 |
| Q2 2025 | -60,590 | Reduce 30.12% | 140,580 | $2.68 |
| Q1 2025 | +161,808 | Add 411.08% | 201,170 | $1.41 |
| Q4 2024 | +17,255 | Add 78.05% | 39,362 | $1.99 |
| Q3 2024 | +22,107 | New Buy | 22,107 | $3.15 |
Cliff Asness's ADC Therapeutics Investment FAQs
Cliff Asness first purchased ADC Therapeutics SA (ADCT) in Q3 2024, acquiring 22,107 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ADC Therapeutics SA (ADCT) for 7 quarters since Q3 2024.
Cliff Asness's largest addition to ADC Therapeutics SA (ADCT) was in Q1 2025, adding 201,170 shares worth $283,651.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 237,637 shares of ADC Therapeutics SA (ADCT), valued at approximately $891,141.
As of the Q1 2026 filing, ADC Therapeutics SA (ADCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ADC Therapeutics SA (ADCT) was 237,637 shares, as reported at the end of Q1 2026.